STOCK TITAN

Becton Dickinson & Co. - BDX STOCK NEWS

Welcome to our dedicated news page for Becton Dickinson & Co. (Ticker: BDX), a resource for investors and traders seeking the latest updates and insights on Becton Dickinson & Co..

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Becton Dickinson & Co.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Becton Dickinson & Co.'s position in the market.

Rhea-AI Summary
Navigate BioPharma Services announces collaboration with BD to develop flow cytometry-based companion diagnostics and tools for clinical decisions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.16%
Tags
none
-
Rhea-AI Summary
BD (Becton, Dickinson and Company) to present at healthcare conferences in September.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.03%
Tags
conferences
-
Rhea-AI Summary
BD (Becton, Dickinson and Company) (NYSE: BDX) announces strong Q3 fiscal 2023 results, with a 5.1% increase in revenue to $4.9 billion. The company achieved FDA 510(k) clearance for the updated BD Alaris™ Infusion System, and completed the sale of its Surgical Instrumentation platform. BD Medical expanded customer availability of BD PosiFlush™ SafeScrub, and BD Life Sciences launched the BD FACSDiscover™ S8 Cell Sorter worldwide.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.73%
Tags
earnings
Rhea-AI Summary
BD (Becton, Dickinson and Company) (NYSE: BDX) announces FDA 510(k) clearance for the BD Respiratory Viral Panel (RVP) for BD MAX™ System, a single test that identifies and distinguishes SARS-CoV-2, influenza A, influenza B, and Respiratory Syncytial Virus (RSV) in approximately two hours, helping clinicians quickly diagnose and treat patients during the respiratory season.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.03%
Tags
covid-19
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.18%
Tags
dividends
-
Rhea-AI Summary
BD (Becton, Dickinson and Company) (NYSE: BDX) Announces Appointment of Dr. Joanne Waldstreicher to its Board of Directors
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.19%
Tags
management
Rhea-AI Summary
BD (Becton, Dickinson and Company) (NYSE: BDX) announces FDA 510(k) clearance for updated BD Alaris™ Infusion System, addressing open recalls, updating hardware, software, and cybersecurity, emphasizing commitment to quality and patient care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.71%
Tags
clinical trial
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
clinical trial
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.69%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.75%
Tags
earnings
Becton Dickinson & Co.

NYSE:BDX

BDX Rankings

BDX Stock Data

71.22B
288.21M
0.31%
89.32%
0.72%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Franklin Lakes

About BDX

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.